Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.056 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |